This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 30 Dec 2019  |  Global

    Novel Enzyme Technologies for Pharmaceutical Applications

    A Review of Novel Enzyme Technologies and Enzyme Applications in API Production, Therapeutics, Diagnosis, Medical Detergents, and Enzyme Expression Systems, Including Enzyme Manufacturing for Pharmaceuticals

    The current study discusses the novel enzyme technologies for enzyme discovery and improvement such as directed mutagenesis, metagenomics, artificial intelligence and computational biology approaches and highthroughput technologies used for generation of enzyme variant libraries. Additionally, novel enzyme applications and potential applications in...

    $4,950.00
  2. 17 Dec 2019  |  Global

    Emerging Microbiome Technologies for Applications in Skin Care

    Microbiome-based Innovations Transforming the Personal Care Landscape

    Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...

    $4,950.00
  3. 26 Sep 2019  |  Global

    Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022

    Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry

    Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

    $4,950.00
  4. 20 Sep 2019  |  Global

    Precision Immunotherapy Innovations Transforming Human Health and Wellness

    A Review of Advances in Cell Therapies, Antibodies, Fusion Proteins, and Other Innovative Approaches for Cancer Treatment

    There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

    $4,950.00
  5. 20 Sep 2019  |  Global

    Technological Advances in Biobetter and Biosimilar Platforms

    Therapeutic Outcomes Optimization

    Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

    $4,950.00
  6. 25 Jun 2019  |  Global

    Technologies Transforming the Biomanufacturing Landscape

    Translating Technology Innovation to Market Competitiveness

    Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

    $4,950.00
  7. 30 Apr 2019  |  Global

    Technological Advances Enabling Stem Cells Reprogramming

    Technologies Paving New Avenues to Drive Breakthrough Research Toward the Discovery of Next Generation Therapeutics

    Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient product...

    $4,950.00
  8. 30 Mar 2019  |  Global

    Emerging Opportunities in Synthetic Biology Platforms

    Synthetic Biology as a Profound Transformative Technology

    Synthetic biology is being supported by a convergence of vanguard technologies. In the era of precision medicine and smart cities, synthetic biology plays a crucial role across multiple sectors and industries. Breakthrough technologies are facilitating the successful implementation of synthetic biology approaches, and also helping in addressing the...

    $4,950.00